Navigation Links
Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
Date:10/18/2007

ATLANTA, Oct. 18 /PRNewswire/ -- Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, will feature advances in cancer care at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO) that dramatically reduce treatment times and increase efficiency. The meeting will be held October 28 - November 1 at the Los Angeles Convention Center (Los Angeles, California, USA). Elekta will showcase innovative offerings that optimize productivity and workflow, empowering health care professionals to spend more time on patient care. One important highlight will be the announcement of a new Elekta solution for clinical Volumetric Intensity Modulated Arc Therapy* (VMAT) that more precisely targets tumors and protects surrounding healthy tissue, while drastically reducing radiation therapy treatment times.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO)

Jay Hoey, Executive Vice President Product Creation at Elekta and CEO of IMPAC Medical Systems, an Elekta company, will unveil this improvement over existing Intensity Modulated Radiation Therapy technologies at noon (PDT) October 28 on Elekta booth 1719.

Innovation on display at several Elekta Group booths

More than 11,000 domestic and international participants are expected at the 2007 ASTRO meeting. Elekta, an Ambassador-level sponsor of the event, will feature a wide range of products from the Elekta family of companies all of which highlight personalized efficiency.

"These Elekta innovations represent a singular focus on personalized efficiency - optimizing every step of the care process, to ensure care is focused on the patient and not on the technology," says Joseph K. Jachinowski, President and CEO, Elekta North America.

Further demonstrating its commitment to personalized efficiency, Elekta will showcase:

-- Elekta Synergy(R), the market-leading multi-functional Intensity

Modulated and Image Guided Radiation Therapy (IMRT and IGRT) system

that provides automated workflow tools and 3D volumetric imaging at

the time of treatment.

-- Leksell Gamma Knife(R) Perfexion(TM), the latest generation of Gamma

Knife surgery for cranial radiosurgery and the only radiation

technology that has a specific indication for the treatment of brain

metastases.

-- Elekta Axesse(TM), a whole body, robotic image-guided stereotactic

treatment management system. This cutting edge technology streamlines

workflow through a combination of advanced robotics, integrated

software and patient-friendly immobilization.

Oncology information products demonstrating personalized efficiency will be on display at IMPAC booth 1609. MOSAIQ(TM), image-integrated electronic medical record, MOSAIQ(TM) RTP* suite for treatment planning, the MOSAIQ(TM) Oncology PACS (Picture Archiving and Communications System), an oncology specific PACS and SYNERGISTIQ(TM) will be showcased. SYNERGISTIQ is a unified therapy treatment console environment that eliminates bottlenecks associated with simultaneously managing otherwise complex image-guidance and delivery processes.

Medical Intelligence, an Elekta Company, also will be demonstrating advancements in patient immobilization during radiation treatments at booth 1701. In addition, the iBEAM(R) evo Couchtop - the next generation of homogenous carbon fiber couchtops - will be on display, as well as, the new fully robotic HexaPOD(TM) evo** positioning table for efficient and accurate 6D patient positioning.

These and other Elekta solutions demonstrate Elekta's commitment to making cancer care easier for therapists and patients. "The combination of Elekta and IMPAC clinical solutions are simplifying and streamlining the treatment process to create a better experience for patients, as well as, enhance the efficiency of the clinician, demonstrating our commitment to personalized efficiency," says Jachinowski.

Users' Meeting

Concurrent with the ASTRO show will be the IMPAC and Elekta Radiation Oncology Users' Meeting, Saturday, October 27 at the Pasadena Civic Center (Pasadena, California, USA). Expected to draw more than 1,000 IMPAC and Elekta users, the meeting will focus on optimizing personalized efficiency within the clinic through advanced and dynamic innovations. Participants will attend sessions on EMR workflow featuring MOSAIQ, efficiency and advancements in IGRT and stereotaxy, and business and economic solutions.

*Volumetric Intensity Modulated Arc Therapy (VMAT) and MOSAIQ(TM) RTP are works in progress and not commercially available

**HexaPOD(TM) evo is pending 510(k) clearance from the FDA

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.

With more than 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at http://www.elekta.com.


'/>"/>
SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Wellcentive today announced it has been ... -based community care organization (CCO) with more ... quality reporting and care management solutions and services. ... of quality managers, analysts and care managers while ... serving FamilyCare members. Oregon ...
(Date:2/11/2016)... 2016   BioInformant announces the February 2016 ... Products, Opportunities, Tools, and Technologies – Market Size, Segments, ... The first and only ... industry, BioInformant has more than a decade of historical ... by stem cell type. This powerful 175 page global ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... -- ASAE is introducing a hybrid membership model which ... option of joining or renewing through an organizational purchasing ... size, every employee in any size association or AMC ... available member benefits.   John H. Graham, ... will allow organizations of any size and their employees ...
Breaking Biology Technology:
(Date:2/2/2016)... 2, 2016 This BCC Research report ... by reviewing the recent advances in high throughput ... the field forward. Includes forecast through 2019. ... challenges and opportunities that exist in the bioinformatic ... developers, as well as IT and bioinformatics service ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):